4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-08-053832
$FOLDCIK 0001178879operating
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 10:33 AM ET
Size
7.7 KB
Accession
0001209191-08-053832
Insider Transaction Report
Form 4
Palling David
Sr VP, Technical Operations
Transactions
- Sale
Common Stock
2008-09-29$15.03/sh−2,300$34,558→ 51,816 total - Sale
Common Stock
2008-09-29$16.22/sh−200$3,245→ 51,616 total
Footnotes (3)
- [F1]Sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2008.
- [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.81 to $15.35. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $16.20 to $16.25. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 10:33 AM ET
- Size
- 7.7 KB